Article · 29 Aug 2026
Conference abstract
A novel approach to inhibit human immune deficiency virus (HIV-1) infection by actively neutralizing the antibodies of reverse transcriptase system
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
This work was applied to study the effect of a novel enzymes combination comprising reverse transcriptase and DNA polymerase (VK 25 RD formula) as immunogens to stimulate the formation of neutralizing non-specific mAbs to AMV– RT enzyme that can block the activity of HIV-RT enzyme system by cross reaction for treatment of HIV. Pilot study was applied on ten patients, their immunological data revealed a viral load of more than 1,000 copies/ml by human immune deficiency virus-ribonucleic acid-polymerase chain reaction (HIV-RNA-PCR), positive antibody to HIV-1 and CD4+ T-cell values less than 250 cells/μl. Five patients take this medication in the form of subcutaneous injection of 0.1 cc twice daily for 24 weeks (test group) and the other five contributed to the study by giving only blood samples during 24 weeks (control group). All of the patients showed the same clinical symptoms of HIV/AIDS and wrote consent of acceptance to take this combination therapy. Blood samples were collected from all ten patients at 6, 12, 18 and 24 weeks. At the end of therapy the test group viral loads had reached under the detectable limits (less than 16 copies/ml), significant increases of their CD4 cells count over 500 cells/ μl and the most important finding of great immunological value is that HIV antibodies by Enzyme-Linked Immunosorbent Assay (ELISA) testing were negatives. According to these findings, this therapeutic modality was promising for treating HIV-1 disease and human immunodeficiency syndrome. PDF HTML
Keywords
Subjects
Vaccines & ImmunisationAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Vaccines & Vaccination.
Article · 29 Aug 2026
Advances in Adjuvant Development for Enhanced Vaccine Performance and Long-Term Immune Protection
Article · 20 Jun 2026
Herd Immunity and Its Role in Controlling Infectious Diseases
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Vaccines & Vaccination
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Sherif Salah”